# Adaptimmune Therapeutics PLC: Form 8-K, filed Sep 30, 2019

- Company: [Adaptimmune Therapeutics PLC](/companies/adapy.md) (CIK 1621227)
- Form: 8-K
- Filed: 2019-09-30
- Accepted by EDGAR: Sep 30, 2019, 08:59 ET
- Period: 2019-09-30
- Accession: 0001410578-19-001463
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1621227/000141057819001463/tv529984_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1621227/000141057819001463/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1621227/000141057819001463/tv529984_8k.htm

Filed Sep 30, 2019.
Source: SEC EDGAR, the filing index for accession 0001410578-19-001463. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.
